First Time MDMA Filed for FDA Approval, Questions About Repercussions Unanswered

The first-ever application for midomafetamine, commonly known as MDMA, to be approved as a new therapeutic drug was submitted to the U.S. Food and Drug Administration (FDA) on Tuesday. If approved, it would be the first psychedelic-assisted therapy, but this raises concerns for some experts. Also known as ecstasy, MDMA is a synthetic drug that causes both hallucinogenic and stimulant effects. MDMA is currently listed by the FDA as a Schedule I drug, meaning it is not accepted for medical use and has a high potential for abuse. The FDA’s approval of MDMA therapy would trigger its rescheduling to one that would acknowledge its medical use....